Caulfield Pharma Consulting Ltd (number 12203931) is a private limited company established on 2019-09-12 originating in United Kingdom. This company was registered at 1 Butterburn Close, Newcastle Upon Tyne NE7 7GR. Caulfield Pharma Consulting Ltd is operating under SIC: 74909 which stands for "other professional, scientific and technical activities not elsewhere classified".
Company details
| Name | Caulfield Pharma Consulting Ltd |
| Number | 12203931 |
| Date of Incorporation: | 2019-09-12 |
| End of financial year: | 30 September |
| Address: | 1 Butterburn Close, Newcastle Upon Tyne, NE7 7GR |
| SIC code: |
74909 - Other professional, scientific and technical activities not elsewhere classified |
Moving to the 2 directors that can be found in this company, we can name: Lindsay C. (appointed on 20 January 2020), David C. (appointment date: 12 September 2019). The Companies House reports 2 persons of significant control, namely: David C. owns 1/2 or less of shares, 1/2 or less of voting rights, Lindsay C. owns 1/2 or less of shares, 1/2 or less of voting rights.
Directors
Accounts data
| Date of Accounts | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 |
| Current Assets | 23,457 | 72,025 | 107,518 | 90,604 |
| Fixed Assets | - | 2,386 | 1,813 | 1,932 |
| Total Assets Less Current Liabilities | 9,914 | 11,676 | 71,761 | 58,682 |
People with significant control
| Nature of control: |
25-50% voting rights right to appoint and remove directors 25-50% shares |
| Nature of control: |
25-50% voting rights right to appoint and remove directors 25-50% shares |
Filings
| Download filing | |
|---|---|
|
(AA) Total exemption full accounts data made up to 30th September 2023 filed on: 14th, February 2024 | accounts |
Free Download
(9 pages)
|